{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Spectral AI, Inc."},"Symbol":{"label":"Symbol","value":"MDAIW"},"Address":{"label":"Address","value":"2515 MCKINNEY AVENUE,SUITE 1000, DALLAS, Texas, 75201, United States"},"Phone":{"label":"Phone","value":"972-499-4934"},"Industry":{"label":"Industry","value":"Medical/Dental Instruments"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Spectral MD Holdings, Ltd., a predictive analytics company, develops AI algorithms and optical technology in wound care treatment. It offers DeepView wound imaging solution, an AI technology and multispectral imaging system that provides healing assessments for burn wounds and diabetic foot ulcers. Spectral MD Holdings, Ltd. was incorporated in 2020 and is headquartered in Dallas, Texas."},"CompanyUrl":{"label":"Company Url","value":"https://www.spectralmd.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Jeffrey Thatcher","title":"Chief Scientist"},{"name":"Mary Regan","title":"Vice President-Clinical Affairs"},{"name":"Stan Micek","title":"Chief Operating Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}